Facilitators and Barriers to Cancer Treatment Among Texas Residents
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 120
- 试验地点
- 1
- 主要终点
- 1. Safety and Adverse Events (AEs)
研究概览
简要总结
This trial uses semi-structured interviews and focus groups to determine facilitators and barriers of receiving timely cancer treatment among multiple cancers, across multiple insurance types, throughout Texas
详细描述
Primary Objectives:
Aim 1: To comprehensively assess barriers to and facilitators of receiving timely cancer treatment, via in-depth telephone interviews among a purposive sample of Texas patients with Stage I-IV breast, colorectal, lung, and prostate cancer and diverse backgrounds.
Aim 2: To generate consensus on barriers and facilitators, as well as their relative importance, via focus groups, among carefully selected Texas patients with Stage I-IV breast, colorectal, lung and prostate cancer and diverse backgrounds,
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Health Services Research
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aims 1 and 2
- •In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- •Verbal consent will be obtained
- •Stated willingness to comply with all study procedures and lifestyle considerations and availability for the duration of the study
- •Males and females; Age ≥ 18 years old
- •Documented diagnosis of breast, colorectal, lung, and prostate cancer patients, stage I-IV
- •Either English or Spanish-speaking
排除标准
- •Aims 1 and 2
- •An individual who meets any of the following criteria will be excluded from participation in this study:
- •Patients who are cognitively impaired
- •Pregnant women
研究组 & 干预措施
Semi-structured Interview
Participants will be recruited through the Texas Cancer Registry (TCR).
干预措施: Focus Groups (Other)
Online Focus Group
Participants will be recruited through the Texas Cancer Registry (TCR).
干预措施: Interviews (Other)
结局指标
主要结局
1. Safety and Adverse Events (AEs)
时间窗: Through study completion; an average of 1 year
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
次要结局
未报告次要终点